CSL Limited
Health
Performance
5.6
Risk
Sell
Buy
Curious about the Scores? Learn more.

CSL Limited stock rating and score history

All changes in ratings, performance and outlook tracked over time.

24.08.2026
Barely upright. Still chaotic, but slowly finding some balance.
CMXHF
CSL Limited
120.44
+0.37%
5.6
Sell
Buy
CSL Limited

CSL Limited stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does CSL Limited do? Business model and key facts

Get the full picture of CSL Limited: what it builds, where it operates, and how it makes money.

CSL Limited Profile

Sector: Healthcare

Industry: Biotechnology

Employees (FY): 29000

CSL Limited is a global biopharmaceutical company discovering, developing, and distributing plasma-derived therapies and influenza vaccines through its CSL Behring and Seqirus divisions. Established in 1916, CSL is headquartered in Melbourne, Australia.

shop
Company facts
Gordon Naylor DipCompSc
CEO
29000
Employees worldwide
shop
Performance
-11.03%
Last 12 months
-46.35%
Last 5 years
shop
Growth
$16.03B
Revenue year
$-2,632,919,142
Net income
shop
Valuation
$57.47B
Market Cap
-20.98
Price/Earnings Ratio

Stocks related to CSL Limited

Selected based on industry alignment and relative market positioning.

ARGX
Low-poly 3D Argenx (ARGX) stock icon with a stylized DNA helix, symbolizing healthcare and biotech.
1,053.46
-0.18%
3.3
Sell
Buy
argenx SE
REGN
Low-poly 3D Regeneron (REGN) stock icon with a stylized DNA helix, symbolizing healthcare and biotech.
843.47
-1.00%
3.3
Sell
Buy
Regeneron Pharmaceuticals, Inc.
VRTX
Low-poly 3D Vertex Pharmaceuticals (VRTX) stock icon with a stylized DNA helix, symbolizing healthcare and biotech.
557.96
+0.22%
2.6
Sell
Buy
Vertex Pharmaceuticals Incorporated
MRNA
Moderna, Inc.
148.87
-1.29%
8.1
Sell
Buy
Moderna, Inc.
LZAGY
Lonza Group AG
72.12
+0.28%
1.8
Sell
Buy
Lonza Group AG

CSL Limited fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.